2018 AACR Annual Meeting presentations highlight the clinical utility of Bio-Rad's Droplet Digital PCR technology for discovering epigenetic biomarkers and measuring immunotherapy response
20:00 EDT 13 Apr 2018 |
AAAS
(CG Life) Researchers showcase how droplet digital PCR technology can be used to identify epigenetic biomarkers to determine cancer recurrence after surgery and measure circulating tumor DNA for immunotherapy response.
More From BioPortfolio on "2018 AACR Annual Meeting presentations highlight the clinical utility of Bio-Rad's Droplet Digital PCR technology for discovering epigenetic biomarkers and measuring immunotherapy response"